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Abstract We report here the isolation of a new member of the
ADP-ribosylation factor (ARF)-like family (ARL-6) present in
the J2E erythroleukemic cell line, but not its myeloid variants.
Consistent with this lineage-restricted expression, ARL-6 mRNA
increased with erythropoietin-induced maturation of J2E cells,
and decreased with interleukin 6-induced differentiation of M1
monoblastoid cells. In tissues, ARL-6 mRNA was most abundant
in brain and kidney. While ARL-6 protein was predominantly
cytosolic, its membrane association increased following exposure
to GTP-QS, like many members of the ARF/ARL family. Using
the yeast two-hybrid system, six molecules which interact with
ARL-6 were identified including SEC61L, a subunit of the
heterotrimeric protein conducting channel SEC61p. Co-immu-
noprecipitation of ARL-6 confirmed a stable association between
ARL-6 and SEC61L in COS cells. These results demonstrate
that ARL-6, a novel member of the ADP-ribosylation factor-like
family, interacts with the SEC61L subunit.
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1. Introduction
Leukemic cells displaying the phenotype of one hemopoietic
lineage can suddenly express the features of another lineage in
a process termed hemopoietic lineage switching [1]. J2E eryth-
roleukemic cells are committed to the erythroid pathway, re-
spond to erythropoietin and do not express any markers of
other hemopoietic lineages [2]. However, when cultured under
adverse conditions (i.e. extreme overgrowth and cell death),
occasionally some cells emerged which displayed features of
myeloid cells [3]. These cells were larger, pleiomorphic and
had the appearance of monocytic cells. Ultrastructural alter-
ations were also evident and these cells ceased expressing ery-
throid-speci¢c genes and cell surface markers [3]. In addition,
they displayed numerous cell surface proteins typically asso-
ciated with monocytes and macrophages. These observations
showed that cells committed to the erythroid lineage and ca-
pable of responding to erythropoietin were able to change
hemopoietic lineages and enter the myeloid pathway. This
phenomenon was remarkably similar to the conversion of
mature lymphoid B-cells to macrophages that we had ob-
served previously [1]. Interestingly, several human leukemias
have been described which suddenly switch lineage, demon-
strating that this is not simply a laboratory curiosity and is of
clinical signi¢cance [1].
The Ras superfamily of low molecular weight GTP-binding
proteins can be divided into several subgroups with diverse
functions, including cellular proliferation and di¡erentiation
(Ras), intracellular tra⁄cking (Rab), cytoskeletal remodeling
(Rho) and nuclear transportation (Ran). A common feature
of this superfamily is regulation by GTP hydrolysis, which
cycles between an active GTP-bound, and an inactive GDP-
bound state [4].
The ADP-ribosylation factor (ARF) group is part of the
Ras superfamily and is subdivided into the ARF and ARF-
like (ARL) molecules. There are six members of the ARF
family (ARF1^6) and ¢ve ARL members (ARL1^5). The
best characterized ARF is ARF-1, identi¢ed as a co-factor
required for the cholera-toxin dependent ADP-ribosylation
of the heterotrimeric G protein Gs, which leads to the activa-
tion of adenylate cyclase [5]. While ARF-1 is predominantly
cytosolic in cell fractionation experiments, immuno£uorescent
microscopy has localized ARF-1 speci¢cally to the trans-Gol-
gi network [6]. It has also been proposed that ARF-1 is a
subunit of the coat of Golgi-derived vesicles [7]. Puri¢ed
ARF-1 binds to vesicles in its active GTP-bound form, via
exposure of the amino terminal myristoyl group, which pro-
motes membrane attachment [5]. The N-terminal hydrophobic
K-helix also plays an important role in regulating the mem-
brane localization of ARF-1 [5].
ARFs are also associated with cell signaling, as they are
e¡ective activators of phospholipase D [8]. An ARF-1 guanine
nucleotide exchange factor (ARNO) has been identi¢ed [9,10]
which is dependent upon association with phosphatidylinosi-
tol for activity. This regulation probably occurs through phos-
phatidylinositol binding to the pleckstrin homology domain of
ARNO. The structure of ARF-1 complexed with GDP has
been resolved [11] and it provides the structural basis for
GTP-dependent modulation of membrane binding, the lack
of intrinsic GTPase activity, and the nature of e¡ector binding
surfaces on ARFs. ARF-6, the least conserved ARF member,
has been localized to the cell periphery and, depending on the
nucleotide bound, cycles between the plasma membrane and
intracellular endosomal vesicles [12]. Furthermore, ARF-6
regulates the actin cytoskeletal organization by binding the
Rac1-interacting protein POR1 in a GTP-dependent manner
[13].
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We used di¡erential display in an attempt to isolate lineage
speci¢c genes expressed in J2E erythroleukemic cells [14] that
had undergone erythroid to myeloid lineage switching [15]. A
new member of the ARL family (ARL-6) was identi¢ed and
its transcript was up-regulated during erythropoietin-induced
di¡erentiation of erythroid cells and down-regulated during
interleukin-6-induced macrophage di¡erentiation. A yeast
two-hybrid screen revealed that ARL-6 interacted with the
protein conducting channel subunit SEC61L. This association
was con¢rmed by hemagglutinin (HA)-tagged ARL-6 co-im-
munoprecipitating with SEC61L in COS cells. These results
show that ARL-6, a novel ARL, interacts with the protein
conducting channel SEC61L subunit.
2. Materials and methods
2.1. Molecular cloning of ARL-6
Total RNA was extracted according to the method of Chomczynski
et al. [14], from which poly-A RNA was isolated using the poly-A-
tract mRNA isolation system (Promega, Madison, WI, USA). Di¡er-
ential displays were performed essentially as described by Liang and
Pardee [15] using mRNA from J2E erythroid cells [2] and its myeloid
derivative J2E-NR-m2 [3]. The oligonucleotide PTGC (5P-T11GC-3P)
was used as the reverse-transcriptase primer and primer RP2 (5P-GTG
AGG CGT C-3P) was used to amplify cDNA in the presence of
35S-dCTP. The di¡erential display products were resolved on a 6%
denaturing PAGE gel and exposed to X-ray ¢lm. Di¡erentially dis-
played bands were excised and ampli¢ed by PCR before subcloning
into the pGEM-T-Easy (Promega) vector. Both strands were se-
quenced using the ABI-Prisim method (PE Applied Biosystems,
Branchburg, NJ, USA).
A VZAP total mouse embryo cDNA library (Clontech, Palo Alto,
CA, USA) and pSPORT-J2E cDNA library made from J2E mRNA
using the Superscript system (Gibco-BRL, Gaithersburg, MD, USA)
were screened according to the manufacturer’s instructions. Positive
clones were subcloned into pBSK+ (Stratagene, La Jolla, CA, USA)
and sequenced. Databases (GenBank/EMBL/DDBJ) were searched
using FASTA and BLAST programs of the Genetics Computer
Group software package (Madison, WI, USA).
The 5PRACE protocol was essentially as described by Edwards et
al. [16], using J2E cDNA as the template with the oligonucleotide AS
(5P-GGA GAC TTC CAA GGT CTT AGC TAT CAC TTA AGC
AC-3P) as the 5P extension primer. The PCR reaction was performed
with oligonucleotides P2 (5P-CTG GTT CGG CCC ACC TCT GAA
GGT TCC AGA ATC GAT AG-3P) and P1 (5P-GCT GAA GCC
TTC CAA CG-3P) and the product that hybridized with the 0.4 kb
EcoRI fragment of pSPORT-J2E1/2 subcloned into pGEM-T-Easy
and sequenced. Northern blots were performed using random primed
cDNA (Giga-Prime kit, Bresatec, Adelaide, S.A., Australia) labeled
with 32P-dCTP, hybridized and quantitated by a phosphoimager
445-SI (Molecular dynamics, Sunnyvale, CA, USA).
2.2. Generation of full length and HA-tagged ARL-6 constructs
Full length ARL-6 cDNA was produced by annealing the PCR
product of the 5PRACE clone, generated with the oligonucleotides
M13F (5P-GTA AAA CGA CGG CCA GT-3P) and P1, to the PCR
product of the pSPORT-J2E1/2 clone produced with the oligonucleo-
tides ARL-S1 (5P-CGT TGG AAG GCT TCA GC-3P) and M13R (5P-
GGA AAC AGC TAT GAC CAT G-3P). ARL-6 was tagged at the
carboxyl terminus with HA [17] with the oligonucleotides ARL-HA5
(5P-CTG GAT CCA TGG GCT TGC TGG ACA GAC-3P) and
ARL-HA3 (5P-GGG GAA GCT TCA GGC ATA ATC TGG CAC
ATC ATA AGG GTA CGT CTT CAC AGC TGG G-3P) and sub-
cloned into pBSK+ (pB-ARL-6-HA).
2.3. Transfections and immuno£uorescence
COS cells were transfected with 20 Wg of plasmid DNA (pGL3E-
control, pGL3-ARL-6-HA) by electroporation at 300 V, 800 WF using
a Gene-Pulser II (Bio-Rad, Hercules, CA, USA) and harvested 48 h
post-transfection. For cell fractionation studies, transfected cells were
lysed in 25 mM Tris-HCl, pH 7.5, 100 mM KCl, 5 mM NaCl, 10 mM
MgCl2, 25 mM NaF, 25 mM L-glycerol phosphate, 1 mM vanadate
and 1 mM benzamidine, then centrifuged at 1000Ug for 5 min. The
supernatant was incubated at 37‡C for 30 min with, or without, 50
WM GTP-QS before centrifugation at 100 000Ug for 60 min. For co-
immunoprecipitations cells were lysed in 25 mM Tris-HCl, pH 7.5,
120 mM NaCl, 1% NP-40, 5 mM EDTA, 25 mM NaF, 25 mM L-
glycerol phosphate, 1 mM vanadate and 1 mM benzamidine, then
centrifuged at 1000Ug for 5 min. The supernatants were then incu-
bated with the anti-HA.11 antibodies (BAbCo, Berkeley, CA, USA),
collected with protein A beads, then immunoblotted with anti-HA.11
or anti-SEC61L antibodies (generously provided by W. Mothes, Har-
vard Medical School, Boston, MA, USA) before detection by en-
hanced chemiluminescence (Amersham, Buckinghamshire, UK).
Indirect immuno£uorescence was performed on transfected COS
cells grown on cover slips, ¢xed in 50% methanol/50% acetone, using
HA.11 or anti-SEC61L antibodies and an anti-mouse-FITC (Amer-
sham) secondary antibody. DNA was counterstained with Hoechst
33258 and cells visualized using an MRC-1000/1024 UV laser scan-
ning confocal microscope (Bio-Rad, Hercules, CA, USA).
2.4. Yeast two-hybrid analysis
The yeast two-hybrid procedures used were essentially as described
by Vojtek et al. [18], using the Saccharomyces cerevisiae L40 strain
(MATa, his3v200, trp1-901, leu2-3, 112, ade2, LYS2: :(lexAop)4-
HIS3, URA3: :(lexAop)8-lacZ, GAL4). Wild-type ARL-6 was sub-
cloned into pBTM116 [18] to generate a LexA-ARL-6 fusion. The
L40 strain was transformed with pBTM116-ARL-6 and used as the
‘bait’ to screen a pVP16 cDNA library made from mRNA derived
from the lymphohemapoietic progenitor cell line EML C.1 [19].
Transformants were plated onto HIS3 plates to select for HIS3
reporter activation. Clones replated onto HIS3 plates were then as-
sayed for L-galactosidase (L-gal) activity using the ¢lter assay. The
pBTM116-ARL-6 plasmid was then cured from the HIS3/L-GAL
clones before transformation and then assayed for HIS3 and L-gal
activity. pVP16 plasmids from the cured clones were then rescued
into Escherichia coli and sequenced. These plasmids were subsequently
co-transformed with pBTM116-ARL-6 into L40 cells before HIS3 and
L-gal assays.
3. Results
3.1. Isolation of ARL-6
In an attempt to identify genes involved in the hemopoietic
lineage switch observed between erythroid J2E and the mye-
loid derivative J2E-NR-m2 cells [3], di¡erential display was
performed on cDNA prepared from these two lines (Fig.
1a). Fragments unique to each cell line were isolated, ampli-
¢ed and sequenced. Table 1 summarizes these data. Three of
the cDNAs isolated were known (Rbtn2/LMO2, L-tropomyo-
sin and tartrate resistant acid phosphatase) and two were
novel. Signi¢cantly, the erythroid transcription factor Rbtn2/
LMO2 was isolated from the parental J2E erythroid cells;
deletion of the gene results in anemia and death in utero
[20]. Interestingly, an alternatively spliced form of L-tropo-
myosin was isolated from the J2E-NR-m2 cells [21], tartrate
resistant acid phosphatase [22], normally a marker of osteo-
clast di¡erentiation, was isolated from J2E cells. Northern
blotting con¢rmed the di¡erential expression of these known
Table 1
Di¡erential display fragments
Fragment Size (bp) Source Homology % Identity
1.11 266 J2E-NR-m2 Nil ^
3.8 177 J2E Nil ^
4.10 350 J2E Rbtn2/LMO2 92
5.C 215 J2E-NR-m2 L-TM 99
11.A 258 J2E TRAP 94
Abbrevations: L-TM, L-tropomyosin; TRAP, tartrate resistant acid
phosphatase.
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genes (data not shown). As fragment 1.11 was ubiquitously
expressed it was discarded and fragment 3.8 was analyzed
further.
The original di¡erential display fragment 3.8 was used as a
probe to isolate clones from J2E and total mouse embryo
cDNA libraries. A partial cDNA was isolated from the mur-
ine embryonic library, while an almost full-length cDNA
clone was isolated from the J2E library. The length and se-
quence of the 5P end of the cDNA was con¢rmed using
5PRACE. Although the nucleotide sequence showed no signif-
icant homologies in the databases, the amino acid sequence
showed homology with members of the ARF family of small
GTP-binding proteins (Fig. 1b), the 3.8 clone was most sim-
ilar to Caenorhabditis elegans ARF-1 (43% identity, 65% ho-
mology). Comparison of the amino acid sequence of clone 3.8
with other members of the mammalian ARF family indicated
it was the sixth member of the ARL subfamily (Fig. 1b). In
accordance with the nomenclature of the family the clone was
named ARL-6. It contained all the conserved features of the
ARF family, including an amino-terminal myristoylation site
followed by a predicted hydrophobic K-helix, and a GTP-
binding site.
The 1263 bp full length cDNA (Fig. 1c) contained an open
reading frame of 186 amino acids with a predicted Mr of 20.9
kDa and an isoelectric point of 8.36. A polyadenylation signal
was situated between 1193^1198 bp and a poly-A tail of 53 bp
began at position 1210. There were 153 bp of 5P untranslated
region and 494 bp of 3P untranslated region. The 5P untrans-
lated region contained no additional in-frame or out-of-frame
initiation codons, while the 3P untranslated region contains 10
copies of the AT3 motif implicated in mRNA destabilization
[23]. Indeed, we found that ARL-6 mRNA has a relatively
Fig. 1. Cloning of ARL-6. a: Di¡erential display of cDNAs generated by PCR with the oligonucleotides PTGC (5P-T11GC-3P) and RP2
(5P-CTG AGG CGT C-3P) from two independently prepared poly-A samples of J2E and J2E-NR-m2 (NRm2) cells. A J2E reverse transcrip-
tase negative sample (RT3) is included as a control. The fragment 3.8 that was excised and sequenced is indicated (8). b: Schematic tree dia-
gram of the homology between ARL-6 and members of the ARF/ARL family and two other GTPases, SARA1 and K-Ras using the Pileup
program of the EGCG Wisconsin package (Genetics Computer Group, Madison, WI, USA). Sequence accession numbers are: K-ras (U09793),
SARA1 (P36536), ARF-1 (P10947), ARF-2 (P16500), ARF-3 (P16587), ARF-4 (P21371), ARF-5 (P26437), ARF-6 (P26438), ARL-1 (L28997),
ARL-2 (L13687), ARL-3 (U07151), ARL-4 (P40617), ARL-5 (X78604), ARL-6 (AF031903). c: Nucleotide and deduced amino acid sequence
of ARL-6. Nucleotides are numbered and the deduced amino acid sequence is shown below. A polyadenylation signal found in the 3P untrans-
lated region is double underlined, while putative RNA destabilization motifs (AT3) are underlined. The myristoylated glycine at position two of
the amino acid sequence is in large size font, followed by the predicted hydrophobic K-helix in underlined italics and the GTP-binding site
(P-loop) in underlined large size font. The sequence is available from GenBank/EMBL/DDBJ under accession number AF031903.
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short half life of 4 h in J2E cells (data not shown). The cDNA
size corresponded well with a mRNA of V1.3 kb seen in
Northern blots, suggesting a full-length clone was isolated.
3.2. Expression patterns of ARL-6 mRNA
As ARL-6 was isolated from an erythroid to myeloid
switch, expression during di¡erentiation of these cell types
was examined. To analyze whether ARL-6 transcripts varied
during erythroid di¡erentiation, J2E cells were induced with
erythropoietin. A three-fold induction of ARL-6 transcripts
was observed 12 h after hormonal stimulation and levels
were maintained up to 48 h post induction (Fig. 2a). L-globin
mRNA and hemoglobin production were used as markers of
erythroid di¡erentiation and both increased as expected with
J2E cell di¡erentiation [2]. ARL-6 expression was also studied
during monocyte/macrophage maturation. Immature mono-
blastoid M1 cells were stimulated with interleukin-6 and a
six-fold reduction in ARL-6 expression was observed (Fig.
2b). Lysozyme mRNA served as a marker for macrophage
di¡erentiation and rose predictably. Together these data
show that ARL-6 transcript levels vary in hemopoietic line-
ages and alter with the di¡erentiation status of the cells.
Intriguingly, when mouse tissues were examined, expression
of ARL-6 was very low in hemopoietic organs such as spleen
and bone marrow (Fig. 2c). Several other tissues also had low
expression levels and the highest levels of ARL-6 mRNA were
found in brain and kidney.
3.3. Subcellular localization of ARL-6
To determine the subcellular localization of ARL-6, a car-
boxyl-terminal HA tagged ARL-6 was transiently expressed in
COS cells. Fractionation studies revealed that most of the
ARL-6 protein was cytosolic, and only a small fraction was
present in the particulate/membrane fraction (Fig. 3a). In sup-
port of the cell fractionation data, when ARL-6 subcellular
localization was analyzed by confocal microscopy (Fig. 3e),
Fig. 2. Analysis of ARL-6 mRNA. a: J2E cells stimulated with
erythropoietin (5 U/ml) were harvested and analyzed for hemoglobin
production by benzidine staining [2]. Total RNA was then extracted
and analyzed for ARL-6, L-globin and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) transcript levels. Levels of ARL-6 (clear
histograms) and L-globin (stippled histograms) relative to GAPDH
and the percentage of benzidine positive cells (F-F) are shown to
the right. b: M1 monoblastoid cells were stimulated with interleu-
kin-6 (6 ng/ml) then harvested and analyzed for ARL-6 and
GAPDH transcript levels. Levels of ARL-6 (clear histograms) and
lysozyme (black histograms) relative to GAPDH are shown to the
right. c: Analysis of various mouse tissues for ARL-6 mRNA ex-
pression. Poly-A RNA was isolated from mouse tissues and hy-
bridized to an ARL-6 cDNA probe. The same blot was then
stripped and reprobed with a glyceraldehyde-3-phosphate dehydrog-
enase (GAPDH) cDNA. Lanes are: T, thymus; Lu, lung; Sp,
spleen; BM, bone marrow; K, kidney; Br, brain; I (L), intestine
(large); I (S), intestine (small); St, stomach; Li, liver; H, heart and
SM, smooth muscle
Fig. 3. Analysis of ARL-6 protein and interacting partners. a: Sub-
cellular localization of ARL-6. COS cells transiently expressing HA-
tagged ARL-6 were fractionated into cytosolic (S100) and particu-
late/membrane (P100) components, then immunoblotted with anti-
HA antibodies. Size markers are shown to the right. b: HA-tagged
ARL-6 shows an increased particulate/membrane (P100) localization
upon GTP-QS stimulation. Lysates from transfected COS cells ex-
pressing the HA-tagged ARL-6 were incubated with (+) or without
(3) 50 WM GTP-QS for 30 min prior to fractionation and then im-
munoblotted with anti-HA antibodies. c: The yeast strain L40
[18,19] was co-transfected with the plasmids pBTM116-ARL-6
(ARL-6) or pBTM116-Lyn (Lyn) and pVP16-Aip1-6 (Aip-1^6) or
pVP16-LckBP1 (LckBP-1). The resultant colonies were replated
onto Leu3/Trp3 plates and assayed for L-gal activity by the ¢lter
assay. The known interaction between Lyn and LckBP-1 was used
as a positive control. d: Lysates from COS cells transfected with
HA-tagged ARL-6 were immunoprecipitated with HA-speci¢c anti-
bodies, then probed with anti-SEC61L or anti-HA antibodies.
(e) COS cells transiently expressing HA-tagged ARL-6 were ¢xed
and subjected to indirect immuno£uorescence, stained for ARL-6
with anti-HA antibodies or for SEC61L with anti-SEC61L antibod-
ies and counterstained with Hoechst 33258 for DNA. Cells were vis-
ualized using an MRC-1000/1024 UV laser scanning confocal
microscope (Bio-Rad, Hercules, CA, USA).
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most of the staining was cytoplasmic. As members of the
ARF and ARL families are small GTP-binding proteins, the
e¡ect of the non-hydrolyzable GTP analogue GTP-QS on sub-
cellular localization was investigated. Signi¢cantly, the
amount of particulate/membrane-associated ARL-6 was in-
creased 3^5 fold by GTP-QS (Fig. 3b).
3.4. ARL-6 interacting molecules
In an attempt to identify proteins that interact with ARL-6,
a yeast two-hybrid screen was performed. Of 107 clones
screened 70 were HIS3 positive, 13 of which were also L-gal
positive. After curing, only nine clones reactivated the report-
ers upon reintroduction of the pBTM116-ARL-6 plasmid.
Plasmids from these nine clones were rescued and sequenced,
identifying six ARL-6 interacting proteins, termed Aip-1 to
Aip-6, (Table 2, Fig. 3c). Of the six interacting molecules
only Aip-3 was a previously well characterized protein, with
98% amino acid identity to the human SEC61L subunit of the
protein conducting channel (Table 2). Aip-1 has 91% amino
acid identity with KIA0069, which contains four potential
transmembrane domains, while Aip-6 has 93% amino acid
identity with JWA, a proposed cytoskeletal protein. Curi-
ously, each of the interacting molecules contained potential
hydrophobic K-helices, which may indicate a means of asso-
ciating with ARL-6 via its hydrophobic K-helix. The speci¢c-
ity of the Aip interactions with ARL-6 was shown by their
inability to associate with the unrelated protein tyrosine ki-
nase Lyn (Fig. 3c).
To determine if the ARL-6/SEC61L interaction occurred in
vivo, HA-tagged ARL-6 was immunoprecipitated from trans-
fected COS cells and probed with antibodies for SEC61L. Fig.
3d shows the interaction of SEC61L with ARL-6, which con-
¢rms the interaction of these two molecules in the yeast two-
hybrid system. In addition, confocal microscopy revealed that
SEC61L and ARL-6 had similar staining patterns (Fig. 3e),
suggesting that the two molecules may co-localize within the
cell. Therefore, in addition to associating in the yeast two-
hybrid system and co-immunoprecipitating (Fig. 3c,d),
ARL-6 and SEC61L show similar intracellular localization
patterns (Fig. 3e).
4. Discussion
In an attempt to identify erythroid/myeloid lineage switch
genes using di¡erential display, we have isolated a novel gene
with sequence homology to the Ras superfamily of small mo-
lecular weight GTP-binding proteins, particularly the ARF/
ARL subfamily. The high degree of homology between this
novel gene and members of the ARF/ARL family (35^40%
amino acid identity) suggests that it is the sixth ARL. Of the
15 residues in ARF that interact directly with the bound Mg-
GDP [11], 12 are identical in ARL-6. The notable di¡erences
are a substitution of the alanine-alanine doublet (ARF-1, 24-
GLDAAGK-30) in the Walker sequence [11] with asparagine-
serine (ARL-6, 24-GLDNSGK-30). These residues interact
with the L-phosphate of the Mg-GDP. While the A27 to
N27 substitution in ARL-6 is seen in some ARLs, the A28
to S28 substitution has not been described previously. The
other signi¢cant di¡erence is the substitution of A52 (ARF-
1), which would interact with the K-phosphate of the Mg-
GDP, with S54 (ARL-6). While this substitution is not seen
in other ARF/ARL members, it is present at the homologous
site in Ras. Taken together, these results suggest ARL-6 may
function mechanistically like ARF-1, but is likely to have a
distinct intracellular role.
ARL-6 has a unique expression pattern among the ARF/
ARL family with the highest mRNA levels present in brain
and kidney. This may indicate that ARL-6 has an important
Table 2
Amino acid sequence of ARL-6 interacting proteins (Aip1^6)
Name ARL-6 interacting protein (Aip1-6) sequence Homology %
Identity
Function
Aip-1 1 WCWGDSVCSL VDNRESGTMA EGDNRSSNLL AVETASLEEQ LQGWGEVMLM KIAA0069 91 Proposed
51 ADKVLRWERA WFPPAIMGVV SLLFLIIYYL DPSVLSGVSC FVMFLCLADY transmembrane
101 LVPILAPRIF GSNKWTTEQQ QRFHEICSNL VKTPPKLWAG GNASFPRKKT
151 NVLHEHDHFS CCGGLG
Aip-2 1 SDLERKHLDL KEVALKQFRS VKKMGGDEFC RRYQDQLEAE IEETYANFIK cDNA vc27f05 100 Unknown
51 HNDGKNIFYA ARTPATLFAV MFAMYIISGL TGFIGLNSIA VLCNLVMGLA
101 LTSLCTWAYV KYSGEFREIG TMIDQIAETL WEQVLKPLGF DGGKHKAVCN
151 KLYQSRPDPV SHQAGR
Aip-3 1 PGPTPSGTNV GSSGRSPSKA VAARAAGSTV RQRKNASCGT RSAGRTTSAG SEC61L 98 Translocon
51 TGGMWRFYTE DSPGLKVGPV PVLVMSLLFI AAVFMLHIWG K subunit
Aip-4 1 KRVKEKAVAV HQAEALPGPS LDQWHRSAGE DNDGPVLTDE QKSRIQAMKP cDNA EST02690 100 Unknown
51 MTKEEWDARQ SVIRLLLPFL LLLLPLLLLV LRSLLP
Aip-5 1 AKQRNMAREP RPAPCLGRFL PGLSFRPAGL QGHFQMEQPC SEQSALLPDQ JWA 90 Proposed
51 LPGGGCHDDF GCWVSEPLQH DPRRSHCGAG VHGVRVGSAQ RHPPPDEEQY cytoskeletal
101 PTAFVMVVML PATSSYPCFG G
Aip-6 1 ARRRRQVTPG PATRPGYSDY TQGDSWGEGE GDENEGCDQV ARDLRAEFSA cDNA mo20b06 93 Unknown
51 RASSETKRAP LLPRVGDGSP VLPDKRNGIF PATAAKRTQA RRWPIQALSI
101 LCSLLFAVLL AFLL
The deduced amino acid sequence of Aip1-6 is shown with potential hydrophobic K-helices underlined. The closest homologue (% identity indi-
cated) of each Aip and its function, if known, is also listed. The nucleotide sequences for Aip-1 to Aip-6 have been deposited in the GenBank
database, accession numbers are: Aip-1; AF133669, Aip-2; AF133670, Aip-3; AF133910, Aip-4; AF133911, Aip-5; AF133912, Aip-6;
AF133913.
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function in these tissues, as they both have important secre-
tory vesicle function e.g. neurotransmitter release in the brain
and erythropoietin secretion from the kidney. Although some
members of the ARF/ARL family are ubiquitous, others have
tissue-speci¢c expression patterns. ARF-4 is expressed widely,
while ARF-1, 3 and 5 are found predominantly in kidney [24].
ARF-6, on the other hand, is present at high levels in ovaries
[24]. Of the ARLs, ARL-5 has the highest expression in brain,
intestine and thymus [25]. Interestingly, ARL-6 mRNA levels
increased during erythroid di¡erentiation, but fell as macro-
phage maturation proceeded, suggesting it may play a role in
hemopoietic development. This observation may be signi¢cant
as ARL-6 was isolated following an erythroid to myeloid
lineage switch.
As with other ARF/ARL proteins [24], ARL-6 was found
mainly in the cytoplasm. ARF/ARL molecules bind to phos-
pholipid micelles and membranes in a GTP-dependent man-
ner [26] and our fractionation data demonstrate an increase in
ARL-6 membrane association after stimulation with GTPQS.
These data suggest that ARL-6 may cycle between the cyto-
plasm and membranes in a GTP-dependent manner.
A yeast two hybrid screen and co-immunoprecipitation re-
vealed that ARL-6 could interact with the SEC61L subunit of
the translocon, while confocal microscopy indicated a possible
intracellular co-localization of these two molecules. There are
several points at which ARL-6 could in£uence the SEC61p
complex, including, assembly of the heterotrimeric SEC61p
complex, formation of the SEC61p membrane channel, regu-
lation of the translocation or the lateral channel exit [27]. The
SEC61p complex containing SEC61L is capable of GTP ex-
change activity for the GTP binding signal recognition par-
ticle receptor-K in the translocon [28]. Perhaps, SEC61L with-
in the SEC61p complex acts as a GTP exchange factor for the
novel molecule ARL-6. The precise biological function of the
interaction between ARL-6 and SEC61L awaits elucidation.
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